ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 711741 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 711741; 2) Community: the network communities that were significantly associated with the response to NSC 711741; 3) Molecule: the relationships between components within communities and NSC 711741; 4) MDR: the compounds that were significantly associated with the NSC 711741.

NSC Compound Enrichment Correlation
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0284045326811618 0.31674353
NSC 755523 Null 0.0284045326811618 0.39962798
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0284045326811618 0.25407986
NSC 77039 Null 0.0284045326811618 0.21943862
NSC 87500 Solacongestidine 0.0284045326811618 0.26931616
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0286383688883668 0.62107432
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0286383688883668 0.51784973
NSC 357777 Null 0.0286383688883668 0.31135999
NSC 48526 Null 0.0286383688883668 0.14789052
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.0286383688883668 0.56754509
Total:88  Current:53    [First] [Prev] [Next] [Last]